DSM-5 and Gender Dysphoria

The DSM-5, the diagnostic manual of the American Psychiatric Association, describes gender dysphoria as clinically significant distress arising from a discrepancy between experienced gender identity and sex assigned at birth. The diagnosis replaced the earlier term “gender identity disorder” in 2013. Its history begins in 1980, when the DSM-III included transsexualism as a psychiatric diagnosis. This change in terminology was not primarily scientifically motivated, but followed political and activist pressure to make the classification less stigmatizing—a shift that also had substantive consequences for how the condition is approached.

From disorder to dysphoria: a political decision

By shifting the focus from identity to distress, it was implicitly accepted that gender identity itself should not be regarded as a disorder. At the same time, the diagnosis remained necessary to gain access to reimbursed medical care. The result is a contradictory construct: a condition that is formally not a disorder of identity, but for which treatment consists of extensive physical adaptation to that identity. Critics argue that this has hampered broader research into causes and alternative treatments.

Diagnostic criteria

For adults and adolescents, the DSM-5 requires a persistent discrepancy (of at least six months) between experienced gender and biological sex, accompanied by clinically significant distress or functional impairment. Additional criteria apply to children. The criteria are broad and rely largely on self-report; there is no objective test. Two clinicians may reach different conclusions based on the same interview. The practical process is described under diagnosing gender dysphoria. The criteria and Dutch figures are available at genderzorgnederland.nl.

Validity and reliability: a weak foundation

The empirical basis for the diagnosis is limited. There is no biomarker, neurological test, or objective cutoff point. The variation among those seeking care is considerable: a 35-year-old man with lifelong dysphoria differs fundamentally from a 14-year-old girl who, after using social media, suddenly identifies as a boy—yet both receive the same diagnosis. This heterogeneity undermines its clinical usefulness.

Diagnosis as a gateway to irreversible care

A DSM-5 diagnosis opens the door in the Netherlands to hormones and surgery, interventions with lifelong consequences for fertility, sexual function, and physical health. With a diagnosis resting on such a weak validity basis, this entails considerable risk. The Cass Review (2024) specifically criticized this pathway: weak diagnostics lead too directly to major interventions.

DSM-5-TR (2022): cosmetic adjustments

The 2022 text revision (DSM-5-TR) left the criteria virtually unchanged in substance, but adjusted the language and terminology in line with activist preferences (“sex assigned to the person” instead of “biological sex”). The underlying question—when is dysphoria pathology, when is it variation, and when is medical intervention justified—remained unanswered.

DSM-5 versus ICD-11

The ICD-11 went a step further and removed gender variance entirely from psychiatric classification, placing it instead in a chapter on sexual health, without requiring distress. This weakens the access criterion even further. See also ICD-11 and gender variance.